Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Transplantation and Cellular Therapy
|
June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis
Kitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Transplantation and Cellular Therapy
|
January 1, 2023
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Transplantation and Cellular Therapy
|
March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy
|
June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma
Nausheen Ahmed, Alaa Ali, Soyoung Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2019
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Tania Jain, Merav Bar, Ankit J Kansagra, et al.
Transplantation and Cellular Therapy
|
April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Blood Advances
|
May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Blood Advances
|
August 14, 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, et al.
Haematologica
|
February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Transplantation and Cellular Therapy
|
June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis
Kitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Transplantation and Cellular Therapy
|
January 1, 2023
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Transplantation and Cellular Therapy
|
March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy
|
June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma
Nausheen Ahmed, Alaa Ali, Soyoung Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2019
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Tania Jain, Merav Bar, Ankit J Kansagra, et al.
Transplantation and Cellular Therapy
|
April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Blood Advances
|
May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Blood Advances
|
August 14, 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, et al.
Haematologica
|
February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
Page
of 12